Skip to NavigationSkip to content


The safety and efficacy of new surgical and non-surgical interventions are to be assessed as part of a new NICE programme aimed at protecting...
Galen has bolstered its product range by buying the rights to pre-menstrual syndrome treatment Sarafem from Lilly for $295 million.
ReNeuron, the UK biopharmaceutical company specialising in stem cells and neurological disorders, is in discussions with a potential merger partner.
A new UK High Court ruling has given pharma companies the right to block the sale of re-packaged parallel imports that infringe their copyright.
Three pharmaceutical companies, GlaxoSmithKline, Pharmacia and Aventis, face legal action for alleged bribery and inflation of prescription drug...
Smaller local hospitals are to become important centres for developing patient-centred care in a reversal of what the Government calls the iggest is...
The 'risk sharing' scheme to provide multiple sclerosis treatments is a waste of money and scientifically unsound, according to new report.
Fourteen PCTs have been given the go-ahead to develop new and innovative services and improve patient services through community pharmacists.
AstraZeneca has submitted new data on its uperstatincholesterol-lowering drug Crestor to convince the US authorities of its safety profile.
Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches